Free Access
Issue |
Med Sci (Paris)
Volume 30, Number 4, Avril 2014
|
|
---|---|---|
Page(s) | 359 - 365 | |
Section | Microenvironnements tumoraux : conflictuels et complémentaires | |
DOI | https://doi.org/10.1051/medsci/20143004007 | |
Published online | 05 May 2014 |
- Tartour E, Gey A, Sastre-Garau X, et al. Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Res 1994 ; 54 : 6243–6248. [PubMed] [Google Scholar]
- Van Poelgeest MI, Welters MJ, van Esch EM, et al. HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial. J Transl Med 2013 ; 11 : 88. [CrossRef] [PubMed] [Google Scholar]
- Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008 ; 26 : 4410–4417. [CrossRef] [PubMed] [Google Scholar]
- De Chaisemartin L, Goc J, Damotte D, et al. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res 2011 ; 71 : 6391–6399. [CrossRef] [PubMed] [Google Scholar]
- Goc J, Germain C, Vo-Bourgais T, et al. Tertiary lymphoid structure dendritic cells signal a Th1 and cytotoxic immune contexture, and are required for good prognostic value of CD8+ T cells in lung cancer patients. Cancer Res 2014 ; 74 : 705–715. [CrossRef] [PubMed] [Google Scholar]
- Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012 ; 12 : 298–306. [CrossRef] [PubMed] [Google Scholar]
- Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006 ; 6 : 205–217. [CrossRef] [PubMed] [Google Scholar]
- Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 2013 ; 39 : 782–795. [CrossRef] [PubMed] [Google Scholar]
- Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004 ; 22 : 329–360. [CrossRef] [PubMed] [Google Scholar]
- Thomas L. Discussion. In : Lawrence HS, ed. Cellular and humoral aspects of the hypersensitive states. New York : Hoeber-Harper, 1959 : 529–532. [Google Scholar]
- Burnet FM. Immunological aspects of malignant disease. Lancet 1967 ; 289 : 1171–1174. [CrossRef] [Google Scholar]
- Tartour E, Pere H, Maillere B, et al. Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy. Cancer Metastasis Rev 2011 ; 30 : 83–95. [CrossRef] [PubMed] [Google Scholar]
- Hubert S, Abastado JP. Les étapes précoces du processus métastatique. Med Sci (Paris) 2014 ; 30 : 378–384. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Buache E, Rio MC. Le stroma tumoral, un terreau fertile pour la cellule cancéreuse. Med Sci (Paris) 2014 ; 30 : 385–390. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Albrengues J, Meneguzzi G, Gaggioli C. L’invasion des cellules tumorales : quand les fibroblastes s’en mêlent. Med Sci (Paris) 2014 ; 30 : 391–397. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Laurent V, Nieto L, Valet P, Muller C. Tissu adipeux et cancer : une association à haut risque. Med Sci (Paris) 2014 ; 30 : 398–404. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Azzi S, Gavard J. Vaisseaux sanguins et tumeurs ou l’art du dialogue. Med Sci (Paris) 2014 ; 30 : 408–414. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Garrido-Urbani S, Jaquet V, Imhof BA. ERO, NADPH oxydases et vascularisation des tumeurs. Med Sci (Paris) 2014 ; 30 : 415–421. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Heard I, Floret D. Vaccins contre les papillomavirus humains (HPV). Dernières recommandations du Haut conseil de la santé publique, et premiers résultats cliniques et virologiques. Med Sci (Paris) 2013 ; 29 : 1161–1166. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Bruchard M, Ghiringhelli F. Microenvironnement tumoral : cellules régulatrices et cytokines immunosuppressives. Med Sci (Paris) 2014 ; 30 : 429–435. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Galon J, Bindea G, Mlecnik B, et al. Microenvironnement immunitaire et cancer : intérêt de l’Immunoscore pour prédire l’évolution clinique. Med Sci (Paris) 2014 ; 30 : 439–444. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Perros F, Humbert M, Cohen-Kaminsky S. Hypertension artérielle pulmonaire. Med Sci (Paris) 2013 ; 29 : 607–616. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Borriello L, DeClerck YA. Le microenvironnement tumoral et la résistance thérapeutique. Med Sci (Paris) 2014 ; 30 : 445–451. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Robert C, Mateus C. Anticorps anti-CTLA-4. Une avancée thérapeutique majeure dans le traitement du mélanome métastatique. Med Sci (Paris) 2011 ; 27 : 850–858. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Deligne C, Teillaud JL. Le double visage des anticorps monoclonaux en oncologie. Med Sci (Paris) 2013 ; 29 : 57–63. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.